Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
21,06 USD | +2,38% | +1,25% | -2,55% |
Omzet 2024 * | 31,42 mln. 29,38 mln. | Omzet 2025 * | 121 mln. 113 mln. | Marktkapitalisatie | 1,79 mld. 1,67 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -314 mln. -294 mln. | Nettowinst (verlies) 2025 * | -256 mln. -239 mln. | EV/omzet 2024 * | 47,7 x |
Nettoliquiditeiten 2024 * | 291 mln. 272 mln. | Nettoliquiditeiten 2025 * | 223 mln. 208 mln. | EV/omzet 2025 * | 12,9 x |
K/w-verhouding 2024 * |
-5,6
x | K/w-verhouding 2025 * |
-7,47
x | Werknemers | 184 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 98,15% |
Recentste transcriptie over Syndax Pharmaceuticals, Inc.
1 dag | +2,38% | ||
1 week | +1,25% | ||
Lopende maand | -11,51% | ||
1 maand | -1,77% | ||
3 maanden | +4,15% | ||
6 maanden | +66,22% | ||
Lopend jaar | -2,55% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Michael Metzger
CEO | Chief Executive Officer | 53 | 05-05-15 |
Peter Ordentlich
FOU | Founder | 55 | 11-10-05 |
Neil Gallagher
PSD | President | 60 | 10-04-23 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Keith Katkin
BRD | Director/Board Member | 52 | 29-03-17 |
Dennis Podlesak
CHM | Chairman | 66 | 01-12-08 |
Pierre Legault
BRD | Director/Board Member | 63 | 04-01-17 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.12% | 0 M€ | 0,00% | - | |
0.12% | 0 M€ | 0,00% | - | |
0.08% | 2 M€ | -.--% |
Datum | Koers | Variatie | Volume |
---|---|---|---|
26-04-24 | 21,06 | +2,38% | 775 076 |
25-04-24 | 20,57 | -1,06% | 589 013 |
24-04-24 | 20,79 | -0,86% | 367 583 |
23-04-24 | 20,97 | +0,05% | 872 149 |
22-04-24 | 20,96 | +0,77% | 665 136 |
uitgestelde koers Nasdaq, 26 april 2024 om 22:00 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-2,55% | 1,79 mld. | |
+1,51% | 42,75 mld. | |
+8,57% | 41,34 mld. | |
+49,22% | 41,61 mld. | |
-12,36% | 26,59 mld. | |
+8,92% | 25,49 mld. | |
-25,13% | 18,12 mld. | |
+29,17% | 12,24 mld. | |
-3,12% | 11,76 mld. | |
+6,35% | 11 mld. |